Free Trial
ASX:PNR

Pantoro (PNR) Stock Price, News & Analysis

Pantoro logo

About Pantoro Stock (ASX:PNR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.07 million shs
Average Volume
N/A
Market Capitalization
$935.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pantoro Limited, together with its subsidiaries, engages in the gold mining, processing, and exploration activities in Western Australia. The company explores for gold and silver deposits. It holds interest in the Halls Creek Project that includes the Nicolsons Mine located in Kimberley Region of Western Australia. The company was formerly known as Pacific Niugini Limited and changed its name to Pantoro Limited in December 2015. Pantoro Limited was incorporated in 1986 and is based in West Perth, Australia.

Receive PNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pantoro and its competitors with MarketBeat's FREE daily newsletter.

PNR Stock News Headlines

Do You Believe In President Trump? Answer This 1 Question
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
Pantoro Gold Ltd PNTOD
See More Headlines

PNR Stock Analysis - Frequently Asked Questions

Pantoro Limited (ASX:PNR) announced its quarterly earnings data on Thursday, March, 15th. The company reported $0.01 earnings per share for the quarter. Pantoro had a negative trailing twelve-month return on equity of 12.91% and a negative net margin of 21.49%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pantoro investors own include bluebird bio (BLUE), Cummins (CMI), L3 Technologies (LLL), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU) and Esperion Therapeutics (ESPR).

Company Calendar

Last Earnings
3/15/2018
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
Machinery
Current Symbol
ASX:PNR
CIK
N/A
Fax
N/A
Employees
11,200
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.31 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$229.43 million
Price / Cash Flow
5.40
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,450,000,000
Free Float
N/A
Market Cap
$935.83 million
Optionable
Not Optionable
Beta
1.42
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (ASX:PNR) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners